Polymorphisms in the promoter regions of matrix metalloproteinases 1 and 3 and cancer risk: A meta-analysis of 50 case-control studies

Mutagenesis

Volumn 25, Issue 1, 2010, Pages 41-48

  Peng, Bo ^a   Cao, Lihuan ^a   Wang, Wenzhang ^a   Xian, Lingling ^a   Jiang, Deke ^a   Zhao, Jing ^a   Zhang, Zhen ^b   Wang, Xiaoli ^a   Yu, Long ^a  

^a FUDAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERSTITIAL COLLAGENASE; STROMELYSIN;

ARTICLE; CANCER RISK; CIGARETTE SMOKING; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HEAD AND NECK CANCER; HUMAN; KIDNEY CANCER; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PRIORITY JOURNAL; PROMOTER REGION; SYSTEMATIC REVIEW;

COMPUTATIONAL BIOLOGY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 3; NEOPLASMS; ODDS RATIO; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; PUBLICATION BIAS; PUBMED; RISK FACTORS;

EID: 73649085197     PISSN: 02678357     EISSN: 14643804     Source Type: Journal    
DOI: 10.1093/mutage/gep041     Document Type: Article

References (66)

1. Decock, J., Paridaens, R. and Ye, S. (2008) Genetic polymorphisms of matrix metalloproteinases in lung, breast and colorectal cancer. Clin. Genet., 73, 197-211.
2. Ye, S. (2000) Polymorphism in matrix metalloproteinase gene promoters: implication in regulation of gene expression and susceptibility of various diseases. Matrix Biol., 19, 623-629.
3. Su, L., Zhou, W., Asomaning, K., Lin, X. H., Wain, J. C., Lynch, T. J., Liu, G. and Christiani, D. C. (2006) Genotypes and haplotypes of matrix metalloproteinase 1, 3 and 12 genes and the risk of lung cancer. Carcinogenesis, 27, 1024-1029.
4. Fang, S. M., Jin, X., Wang, R. et al. (2005) Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China. Carcinogenesis, 26, 481-486.
5. Woolf, B. (1955) On estimating the relation between blood group and disease. Ann. Hum. Genet., 19, 251-253.
6. Cochran, W. G. (1954) The combination of estimates from different experiments. Biometrics, 10, 101-129.
7. DerSimonian, R. and Kacker, R. (2007) Random-effects model for meta-analysis of clinical trials: an update. Contemp. Clin. Trials, 28, 105-114.
8. Mantel, N. and Haenszel, W. (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl Cancer Inst., 22, 719-748.
9. Higgins, J. P. T., Thompson, S. G., Deeks, J. J. and Altman, D. G. (2003) Measuring inconsistency in meta-analyses. Br. Med. J., 327, 557-560.
10. Begg, C. B. and Mazumdar, M. (1994) Operating characteristics of a bank correlation test for publication bias. Biometrics, 50, 1088-1101.
11. Egger, M., Smith, G. D., Schneider, M. and Minder, C. (1997) Bias in meta-analysis detected by a simple, graphical test. Br. Med. J., 315, 629-634.
12. Schabath, M. B., Delclos, G. L., Martynowicz, M. M., Greisinger, A. J., Lu, C., Wu, X. F. and Spitz, M. R. (2005) Opposing effects of emphysema, hay fever, and select genetic variants on lung cancer risk. Am. J. Epidemiol., 161, 412-422.
13. Biondi, M. L., Turri, O., Leviti, S., Seminati, R., Cecchini, F., Bernini, M., Ghilardi, G. and Guagnellini, E. (2000) MMP1 and MMP3 polymorphisms in promoter regions and cancer. Clin. Chem., 46, 2023-2024.
14. Zhang, W., Lin, H., Zhou, Y., Wang, Y. and Cheng, Q. (2006) Association of MMP1 -1607(1G.2G) single nucleotide polymorphism with susceptibility to lung cancer in Northwestern Chinese population of Han nationality. Chin. J. Med. Genet., 23, 313-315.
15. Lievre, A., Milet, J., Carayol, J. et al. (2006) Genetic polymorphisms of MMP1, MMP3 and MMP7 gene promoter and risk of colorectal adenoma. BMC Cancer, 6, 270-277.
16. Xu, E. P., Lai, M. D., Lu, B. J., Xing, X. M. and Huang, Q. (2006) No association between the polymorphisms in matrix metalloproteinase-1 and matrix metalloproteinase-3 promoter regions and colorectal cancer in Chinese. Dis. Colon Rectum, 49, 1439-1444.
17. Hinoda, Y., Okayama, N., Takano, N. et al. (2002) Association of functional polymorphisms of matrix metalloproteinase (MMP)-1 and MMP-3 genes with colorectal cancer. Int. J. Cancer, 102, 526-529.
18. Woo, M., Park, K., Nam, J. and Kim, J. C. (2007) Clinical implications of matrix metalloproteinase-1, -3, -7, -9, -12, and plasminogen activator inhibitor-1 gene polymorphisms in colorectal cancer. J. Gastroenterol. Hepatol., 22, 1064-1070.
19. Elander, N., Soderkvist, P. and Fransen, K. (2006) Matrix metalloproteinase (MMP)-1, -2, -3 and -9 promoter polymorphisms in colorectal cancer. Anticancer Res., 26, 791-795.
20. Vairaktaris, E., Serefoglou, Z., Avgoustidis, D. et al. (2009) Gene polymorphisms related to angiogenesis, inflammation and thrombosis that influence risk for oral cancer. Oral Oncol., 45, 247-253.
21. Ghilardi, G., Biondi, M. L., Caputo, M., Leviti, S., DeMonti, M., Guagnellini, E. and Scorza, R. (2002) A single nucleotide polymorphism in the matrix metalloproteinase-3 promoter enhances breast cancer susceptibility. Clin. Cancer Res., 8, 3820-3823.
22. Kader, A. K., Shao, L. N., Dinney, C. P., Schabath, M. B., Wang, Y. F., Liu, J., Gu, J., Grossman, H. B. and Wu, X. F. (2006) Matrix metalloproteinase polymorphisms and bladder cancer risk. Cancer Res., 66, 11644-11648.
23. Hirata, H., Okayama, N., Naito, K., Inoue, R., Yoshihiro, S., Matsuyama, H., Suehiro, Y., Hamanaka, Y. and Hinoda, Y. (2004) Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma. Carcinogenesis, 25, 2379-2384. (Pubitemid 39625178)
24. Hashimoto, T., Uchida, K., Okayama, N. et al. (2004) Association of matrix metalloproteinase (MMP)-1 promoter polymorphism with headand neck squamous cell carcinoma. Cancer Lett., 211, 19-24. (Pubitemid 38759765)
25. Nishizawa, R., Nagata, M., Noman, A. A. et al. (2007) The 2G allele of promoter region of matrix metalloproteinase-1 as an essential pre-condition for the early onset of oral squamous cell carcinoma. BMC Cancer, 7, 187.
26. Zhai, Y., Qiu, W., Dong, X. J., Zhang, X. M., Xie, W. M., Zhang, H. X., Yuan, X. Y., Zhou, G. Q. and He, F. C. (2007) Functional polymorphisms in the promoters of MMP-1, MMP-2, MMP-3, MMP-9, MMP-12 and MMP-13 are not associated with hepatocellular carcinoma risk. Gut, 56, 445-447.
27. Lu, Z. Q., Cao, Y. Y., Wang, Y. M. et al. (2007) Polymorphisms in the matrix metalloproteinase-1, 3, and 9 promoters and susceptibility to adult astrocytoma in northern China. J. Neurooncol., 85, 65-73.
28. Li, Y., Jin, X., Kang, S., Wang, Y., Du, H., Zhang, J. H., Guo, W., Wang, N. and Fang, S. M. (2006) Polymorphisms in the promoter regions of the matrix metalloproteinases-1,-3,-7, and-9 and the risk of epithelial ovarian cancer in China. Gynecol. Oncol., 101, 92-96.
29. Nishioka, Y., Sagae, S., Nishikawa, A., Ishioka, S. and Kudo, R. (2003) A relationship between matrix metalloproteinase-1 (MMP-1) promoter polymorphism and cervical cancer progression. Cancer Lett., 200, 49-55.
30. Nishioka, Y., Kobayashi, K., Sagae, S. et al. (2000) A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter in endometrial carcinomas. Jpn. J. Cancer Res., 91, 612-615.
31. Kanamori, Y., Matsushima, M., Minaguchi, T., Kobayashi, K., Sagae, S., Kudo, R., Terakawa, N. and Nakamura, Y. (1999) Correlation between expression of the matrix metalloproteinase-1 gene in ovarian cancers and an insertion/deletion polymorphism in its promoter region. Cancer Res., 59, 4225-4227.
32. Zhu, Y., Spitz, M. R., Lei, L., Mills, G. B. and Wu, X. F. (2001) A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility. Cancer Res., 61, 7825-7829.
33. Albayrak, S., Canguven, O., Goktas, C., Aydemir, H. and Koksal, V. (2007) Role of MMP-1 1G/2G promoter gene polymorphism on the development of prostate cancer in the Turkish population. Urol. Int., 79, 312-315.
34. Ben Nasr, H., Mestiri, S., Chahed, K., Bouaouina, N., Gabbouj, S., Jalbout, M. and Chouchane, L. (2007) Matrix metalloproteinase-1(-1607) 1G/2G and -9(1562) C/T promoter polymorphisms: susceptibility and prognostic implications in nasopharyngeal carcinomas. Clin. Chim. Acta, 384, 57-63.
35. Cao, Z. G. and Li, C. Z. (2006) A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances oral squamous cell carcinoma susceptibility in a Chinese population. Oral Oncol., 42, 32-38.
36. Gonzalez-Arriaga, P., Lopez-Cima, M. F., Fernandez-Somoano, A., Pascual, T., Marron, M. G., Puente, X. S. and Tardon, A. (2008) Polymorphism+17 C/G in matrix metalloprotease MMP8 decreases lung cancer risk. BMC Cancer, 8, 12.
37. Hirata, H., Naito, K., Yoshihiro, S., Matsuyama, H., Suehiro, Y. and Hinoda, Y. (2003) A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter is associated with conventional renal cell carcinoma. Int. J. Cancer, 106, 372-374.
38. Jin, X., Kuang, G., Wei, L.-Z. et al. (2005) No association of the matrix metalloproteinase 1 promoter polymorphism with susceptibility to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma in northern China. World J. Gastroenterol., 11, 2385-2389. (Pubitemid 40667969)
39. Ju, W., Kim, J. W., Park, N. H., Song, Y. S., Kim, S. C., Kang, S. B. and Lee, H. P. (2007) Matrix metalloproteinase-1 promoter polymorphism and epithelial ovarian cancer: does ethnicity matter? J. Obstet. Gynaecol. Res., 33, 155-160.
40. Ju, W., Kang, S. B., Kim, J. W., Park, N. H., Song, Y. S. and Lee, H. P. (2005) Promoter polymorphism in the matrix metalloproteinase-1 and risk of cervical cancer in Korean women. Cancer Lett., 217, 191-196.
41. Krippl, P., Langsenlehner, U., Renner, W., Yazdani-Biuki, B., Koppel, H., Leithner, A., Wascher, T. C., Paulweber, B. and Samonigg, H. (2004) The 5A/6A polymorphism of the matrix metalloproteinase 3 gene promoter and breast cancer. Clin. Cancer Res., 10, 3518-3520. (Pubitemid 38685461)
42. Lai, H. C., Chu, C. M., Lin, Y. W., Chang, C. C., Nieh, S., Yu, M. H. and Chu, T. Y. (2005) Matrix metalloproteinase 1 gene polymorphism as a prognostic predictor of invasive cervical cancer. Gynecol. Oncol., 96, 314-319.
43. Lei, H. X., Zaloudik, J. and Vorechovsky, I. (2002) Lack of association of the -1171 (5A) allele of the MMP3 promoter with breast cancer. Clin. Chem., 48, 798-799.
44. Lin, S. C., Chung, M. Y., Huang, J. W., Shieh, T. M., Liu, C. J. and Chang, K. W. (2004) Correlation between functional genotypes in the matrix metalloproteinases-1 promoter and risk of oral squamous cell carcinomas. J. Oral Pathol. Med., 33, 323-326.
45. Matsumura, S., Oue, N., Kitadai, Y. et al. (2004) A single nucleotide polymorphism in the MMP-1 promoter is correlated with histological differentiation of gastric cancer. J. Cancer Res. Clin. Oncol., 130, 259-265.
46. McCready, J., Broaddus, W. C., Sykes, V. and Fillmore, H. L. (2005) Association of a single nucleotide polymorphism in the matrix metalloproteinase- 1 promoter with glioblastoma. Int. J. Cancer, 117, 781-785.
47. O-Charoenrat, P., Leksrisakul, P. and Sangruchi, S. (2006) A functional polymorphism in the matrix metalloproteinase-1 gene promoter is associated with susceptibility and aggressiveness of headand neck cancer. Int. J. Cancer, 118, 2548-2553.
48. Ohtani, H., Maeda, N. and Murawaki, Y. (2009) Functional polymorphisms in the promoter regions of matrix metalloproteinase-2,-3,-7,-9 and TNFalpha genes, and the risk of colorectal neoplasm in Japanese. Yonago Acta Med., 52, 47-56.
49. Ozgen, A. G., Karadeniz, M., Erdogan, M. and Berdeli, A. (2008) Matrix metalloproteinases (MMP)-1, -2, and -9 gene polymorphism in papillary thyroid cancers (PTC). Endocrinologist, 18, 137-141.
50. Piccoli, M. F., Figueira, M., Andreoni, C., Marumo, J. T., Schor, N. and Bellini, M. H. (2007) Lack of association between matrix metalloproteinase- 1 (MMP-1) promoter polymorphism and risk of renal cell carcinoma. Int. Braz. J. Urol., 33, 622-629.
51. Shimizu, Y., Kondo, S., Shirai, A., Furukawa, M. and Yoshizaki, T. (2008) A single nucleotide polymorphism in the matrix metalloproteinase-1 and interleukin-8 gene promoter predicts poor prognosis in tongue cancer. Auris Nasus Larynx, 35, 381-389.
52. Smolarz, B., Szyllo, K., Romanowicz-Makowska, H., Niewiadomski, M., Kozlowska, E. and Kulig, A. (2004) PCR analysis of matrix metalloproteinase 3 (MMP-3) gene promoter polymorphism in ovarian cancer. Pol. J. Pathol., 54, 233-238.
53. Su, L., Zhou, W., Park, S., Wain, J. C., Lynch, T. J., Liu, G. and Christiani, D. C. (2005) Matrix metalloproteinase-1 promoter polymorphism and lung cancer risk. Cancer Epidemiol. Biomarkers Prev., 14, 567-570.
54. Sugimoto, M., Yoshida, S., Kennedy, S., Deguchi, M., Ohara, N. and Maruo, T. (2006) Matrix metalloproteinase-1 and -9 promoter polymorphisms and endometrial carcinoma risk in a Japanese population. J. Soc. Gynecol. Invest., 13, 523-529.
55. Tasci, A. I., Tugcu, V., Ozbek, E., Ozbay, B., Simsek, A. and Koksal, V. (2008) A single-nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances bladder cancer susceptibility. BJU Int., 101, 503-507.
56. Ye, S., Dhillon, S., Turner, S. J., Bateman, A. C., Theaker, J. M., Pickering, R. M., Day, I. and Howell, W. M. (2001) Invasiveness of cutaneous malignant melanoma is influenced by matrix metalloproteinase 1 gene polymorphism. Cancer Res., 61, 1296-1298.
57. Zhang, J. H., Jin, X., Fang, S. M. et al. (2004) The functional SNP in the matrix metalloproteinase-3 promoter modifies susceptibility and lymphatic metastasis in esophageal squamous cell carcinoma but not in gastric cardiac adenocarcinoma. Carcinogenesis, 25, 2519-2524.
58. Zinzindohoue, F., Blons, H., Hans, S. et al. (2004) Single nucleotide polymorphisms in MMP1 and MMP3 gene promoters as risk factor in headand neck squamous cell carcinoma. Anticancer Res., 24, 2021-2026.
59. Kouhkan, F., Motovali-Bashi, M. and Hojati, Z. (2008) The influence of interstitial collagenas-1 genotype polymorphism on colorectal cancer risk in Iranian population. Cancer Invest., 26, 836-842.
60. Rutter, J. L., Mitchell, T. I., Buttice, G., Meyers, J., Gusella, J. F., Ozelius, L. J. and Brinckerhoff, C. E. (1998) A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res., 58, 5321-5325.
61. Broderick, P., Carvajal-Carmona, L., Pittman, A. M. et al. (2007) A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer risk. Nat. Genet., 39, 1315-1317.
62. Tomlinson, I., Webb, E., Carvajal-Carmona, L. et al. (2007) A genomewide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8-24.21. Nat. Genet., 39, 984-988.
63. Wrensch, M., Jenkins, R. B., Chang, J. S. et al. (2009) Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat. Genet., 41, 905-908.
64. Gudmundsson, J., Sulem, P., Gudbjartsson, D. F. et al. (2009) Common variants on 9-22.33 and 14-13.3 predispose to thyroid cancer in European populations. Nat. Genet., 41, 460-464.
65. Amos, C. I., Wu, X. F., Broderick, P. et al. (2008) Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15-25.1. Nat. Genet., 40, 616-622.
66. Hung, R. J., McKay, J. D., Gaborieau, V. et al. (2008) A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15-25. Nature, 452, 633-637.